Niche Specialization Array Biostatistics operates as a specialized biostatistical and statistical programming CRO within the pharmaceutical manufacturing industry, which suggests a targeted service offering that could appeal to biopharma companies seeking expert statistical support for clinical trials.

Growth Acquisition The company's recent acquisition by Cato SMS indicates a strategic move to expand its clinical research solutions, presenting opportunities to leverage additional resources and network connections for upselling integrated service packages.

Limited Revenue With annual revenues estimated below one million dollars, Array represents a smaller player in the clinical research space, often leading larger competitors, which may open doors for offering scalable, flexible services tailored to their growth stage.

Industry Focus Positioned within the pharmaceutical manufacturing sector with capabilities in biostatistics, the company presents opportunities to cross-sell to pharmaceutical firms investing heavily in clinical trial data analysis and regulatory submissions.

Technology Usage Utilizing a modern tech stack including WordPress, MySQL, and Google Analytics, Array demonstrates an openness to digital and software-based solutions, making it a suitable candidate for introducing advanced data management, automation, or cloud-based analytics tools to enhance their offerings.